Teva and Novartis reach settlement on Famvir suit
Under terms of the settlement, Teva will make a one-time payment to Novartis as well as ongoing royalty fees on U.S. sales of generic Famvir.
If you enjoyed this post, make sure you subscribe to my RSS feed!
